Elena Pintea
Drug Safety Scientist, Pharmacovigilance and Pharmacist
I help make sure medicines are safe for the people who rely on them, combining more than ten years of hospital and community pharmacy with research into drug-induced immune responses.
Zürich, Switzerland
About me
I'm a licensed pharmacist and Drug Sciences graduate (MSc, University of Basel) with a research background in immunopharmacology, metabolomics and drug-induced immunomodulation. I'm trained in toxicology, ICH-GCP and the regulatory frameworks that govern drug safety evaluation.
My thesis examined how pharmacological agents change the inflammatory and metabolic responses of macrophages, work that applies directly to understanding immune-mediated adverse drug reactions and characterising safety signals. I combine this with hands-on hospital and Swiss community pharmacy experience, and I'm looking to contribute to pharmacovigilance and drug safety teams in pharmaceutical companies or CROs.
- Pharmacy practice
- Since 2014
- Drug safety research
- Since 2025
- Education
- MSc Drug Sciences, University of Basel
- Licensed
- Swiss Pharmacist Licence, MEBEKO recognition
Experience
Most recent first, in each discipline.
Drug safety research
-
Apr 2025 - Jan 2026
Master's Thesis: Drug-Induced Immunomodulation & Macrophage Safety Profiling
Zampieri Lab, University of Basel, SwitzerlandInvestigated how pharmacological agents alter the metabolic and inflammatory behaviour of macrophages after LPS stimulation, which is directly relevant to understanding immune-mediated adverse drug reactions.
-
Apr 2025 - Jan 2026
Laboratory Methods & Data Analysis
Zampieri Lab, University of Basel, SwitzerlandApplied ELISA cytokine quantification and FIA-MS metabolomics to characterise drug-induced cellular responses, and identified key metabolic shifts behind macrophage activation that add to the mechanistic understanding of drug-induced toxicity.
-
Apr 2025 - Jan 2026
Scientific Documentation
Zampieri Lab, University of Basel, SwitzerlandProduced structured scientific documentation and data analysis outputs consistent with regulatory research standards, relevant to preclinical safety assessment and pharmacovigilance signal evaluation.
Pharmacy practice
-
Feb 2025 - today
Pharmacist
Coop Vitality Feuerthalen, Switzerland, part-timeCounselling patients on safe and effective medication use, and identifying, documenting and escalating suspected adverse drug reactions in line with Swiss reporting requirements. Ensuring regulatory compliance across prescription management, product storage and pharmacy operations, and supporting the lead pharmacist with daily operations and quality standards.
-
Jun 2023 - Sep 2024
Registered Pharmacist
Amavita Bülach, SwitzerlandProvided patient counselling focused on medication safety, drug interactions and contraindications. Identified and flagged suspected adverse drug reactions, kept accurate patient medication records and supported compliance in prescription handling and inventory management.
-
Sep 2017 - Jun 2018
Pharmacist & Supervisor, Hospital Setting
Catena S.R.L., RomaniaAnalysed dosages and therapeutic appropriateness for hospital patients and coordinated with clinical teams on prescription safety, while maintaining patient profiles and prescription records in a regulated clinical environment.
-
Jan 2014 - Aug 2017
Hospital Pharmacist, Surgery Unit
National Hospital, MoldovaManaged peri-surgical medication for post-operative patients in a multi-team hospital environment, coordinating medication planning with surgical teams and keeping patient and prescription records rigorously up to date.
Core competencies
What I bring to a drug safety or pharmacovigilance team.
Pharmacovigilance
- Adverse event assessment
- Pharmacovigilance reporting
- Signal detection principles
- Drug safety literature review
- Swiss adverse drug reaction reporting
Toxicology and safety science
- Mechanisms of toxicity
- Immunosafety
- Clinical toxicology
- Early safety assessment and 3Rs
- Safety assessment for first-in-human trials
Laboratory and data
- ELISA cytokine quantification
- FIA-MS metabolomics
- Scientific data analysis
- Structured scientific documentation
Regulatory and quality
- ICH-GCP compliance
- Regulatory documentation
- Regulatory aspects of drug approval
- Quality and compliance in pharmacy operations
Clinical pharmacy
- Patient counselling on medication safety
- Drug interactions and contraindications
- Dosage and therapeutic review
- Peri-surgical medication management
Ways of working
- Attention to detail
- Scientific communication
- Cross-functional collaboration
- Problem-solving and adaptability
- Regulatory mindset
Education and credentials
Education
- MSc Drug Sciences University of Basel, Switzerland, 2026, grade 5.0/6.0
- Diploma de Licență, Pharmacy Ovidius University of Constanța, Romania, 2014, 300 ECTS, ranked 57 of 204
Licences
- 2024 Swiss Pharmacist Licence, MEBEKO recognition (federal level)
- 2017 Romanian College of Pharmacists, member certificate
Certificates
- 2024 Good Clinical Practice (GCP), ICH Guidelines for Investigators and Study Teams
- 2024 Drug Safety & Database Research Seminar, University of Basel
- 2023 Scientific Writing Seminar, University of Basel
- 2017 Pharmaceutical Legislation & Good Practice, Romanian College of Pharmacists
- 2017 Epigenetics in Tumours, Continuing Pharmaceutical Education
Drug safety and toxicology training
MSc modules completed at the University of Basel.
- Mechanisms of Toxicity
- Organ-directed Toxicity
- Immunosafety
- Reproductive Toxicology
- Clinical Toxicology
- Psychopharmacology & Neurotoxicology
- Early Safety Assessment & 3Rs
- Safety Assessment for First-in-Human Trials
- Animal Experimentation for Regulatory Purposes
- Pharmacogenomics
- Regulatory Aspects for Approval of Therapeutics
- Targets & Therapeutics in Immune Pharmacology
- Mechanisms of Drug Action
- Chemical Risk Assessment
- Environmental & Food Toxicology
- Drug Delivery and Targeting
Research
Drug-Induced Immunomodulation & Macrophage Safety Profiling
Master's thesis, Zampieri Lab, University of Basel, 2026.
How pharmacological agents reshape macrophage metabolism and inflammation
ELISA cytokine quantification and FIA-MS metabolomics after LPS stimulation, with implications for preclinical safety assessment and the evaluation of immune-mediated safety signals.
Languages
- Romanian, native
- English, C1
- German, B2
- French, A1–A2
Technical skills
- Adverse Event Assessment
- ICH-GCP Compliance
- Pharmacovigilance Reporting
- ELISA Cytokine Quantification
- FIA-MS Metabolomics
- Signal Detection Principles
- Regulatory Documentation
- Scientific Data Analysis
- Drug Safety Literature Review
- Microsoft Office Suite
Let's work together
References are available on request.